Search - tctmd.com

Displaying 281 - 300 of 1554

Sort: Relevancy | Date

Presentation NY Valves 2024

Impact of Bioprosthetic Valve Performance on 5-year Clinical Outcomes in Patients at Intermediate or Greater Surgical Risk

Presenter: Steven J. Yakubov

June 07, 2024

Presentation NY Valves 2024

UPDATES: Pre-emptive AVR Clinical Trials for Moderate and Severe AS

Presenter: Philippe Pibarot

June 07, 2024

Presentation NY Valves 2024

Managing Multi-Valvular Disease and Considerations for Surgical Eligibility

Presenter: Joshua Goldberg

June 07, 2024

Presentation NY Valves 2024

Assessing Functional Status and Predicting Clinical Improvement

Presenter: Suzanne V. Arnold

June 07, 2024

Presentation NY Valves 2024

The Importance of Baseline Hemodynamics and Tricuspid Anatomy

Presenter: Philipp Lurz

June 07, 2024

Presentation NY Valves 2024

Real World TTVI Registries: Is There Concordance With the Randomized Trials?

Presenter: Bassem M. Chehab

June 07, 2024

Presentation NY Valves 2024

T-TEER - TRILUMINATE

Presenter: Brian K. Whisenant

June 07, 2024

Presentation NY Valves 2024

Transcatheter Tricuspid Valve Replacement - TRISCEND II

Presenter: Raj Makkar

June 07, 2024

Presentation NY Valves 2024

Expanding Indications for LAAO to Front Line Therapy for Stroke Reduction in AF: Clinical Trial Updates

Presenter: Shephal K. Doshi

June 06, 2024

Presentation NY Valves 2024

Pre-emptive AVR for Moderate AS and Asymptomatic Severe AS: A Summary of Upcoming Trials

Presenter: Nicolas M. Van Mieghem

June 06, 2024

Presentation NY Valves 2024

Patient Selection: From Clinical Trials to “On Label” to Real World – Who Are the Right Candidates for LAAO?

Presenter: Samir R. Kapadia

June 06, 2024

Presentation NY Valves 2024

Incidence, Predictors, and Management of Conduction Disturbances After Transcatheter Tricuspid Valve Replacement: The TRIPLACE Registry

Presenter: Andrea Scotti

June 06, 2024

Presentation NY Valves 2024

Surgical Mitral Valve Replacement With a Novel Polymeric Valve: 30-day Results From a Global Clinical Study of the Foldax TRIA Mitral Valve

Presenter: Isaac George

June 06, 2024

Presentation NY Valves 2024

Impact of Tricuspid Regurgitation on Right Heart Remodeling: Insights From the TRILUMINATE Pivotal MRI and CT Imaging Substudy

Presenter: Joao L. Cavalcante

June 06, 2024

Presentation NY Valves 2024

T-TEER in a Broad Range of Anatomies: Results From the TRILUMINATE Pivotal Trial

Presenter: Brian K. Whisenant

June 06, 2024

Presentation NY Valves 2024

The Future of Transcatheter Tricuspid Intervention: What’s Missing in Technology and Clinical Trials?

Presenter: Azeem Latib

June 06, 2024

Presentation NY Valves 2024

Designing Trials to Assess the Effectiveness of New VHD Screening Strategies

Presenter: Timothy Joseph Poterucha

June 06, 2024

Presentation NY Valves 2024

Long-term Follow-up in VHD Clinical Trials: Much Needed, BUT Difficult to Do

Presenter: Mauro Moscucci

June 06, 2024

Presentation NY Valves 2024

Requirements for GDMT in UPSTREAM AVR Clinical Trials in (1) Preserved EF or (2) Reduced EF Patients

Presenter: Parag Goyal

June 05, 2024

Presentation NY Valves 2024

Phenotypic Diversity in Secondary Mitral Regurgitation: Differential Outcomes Following Transcatheter Edge-to-Edge Repair - Insights From the COAPT and MITRA-FR Trials

Presenter: Guillaume Bonnet

June 05, 2024

Advertisement

Impact of Bioprosthetic Valve Performance on 5-year Clinical Outcomes in Patients at Intermediate or Greater Surgical Risk

UPDATES: Pre-emptive AVR Clinical Trials for Moderate and Severe AS

Managing Multi-Valvular Disease and Considerations for Surgical Eligibility

Assessing Functional Status and Predicting Clinical Improvement

The Importance of Baseline Hemodynamics and Tricuspid Anatomy

Real World TTVI Registries: Is There Concordance With the Randomized Trials?

T-TEER - TRILUMINATE

Transcatheter Tricuspid Valve Replacement - TRISCEND II

Expanding Indications for LAAO to Front Line Therapy for Stroke Reduction in AF: Clinical Trial Updates

Pre-emptive AVR for Moderate AS and Asymptomatic Severe AS: A Summary of Upcoming Trials

Patient Selection: From Clinical Trials to “On Label” to Real World – Who Are the Right Candidates for LAAO?

Incidence, Predictors, and Management of Conduction Disturbances After Transcatheter Tricuspid Valve Replacement: The TRIPLACE Registry

Surgical Mitral Valve Replacement With a Novel Polymeric Valve: 30-day Results From a Global Clinical Study of the Foldax TRIA Mitral Valve

Impact of Tricuspid Regurgitation on Right Heart Remodeling: Insights From the TRILUMINATE Pivotal MRI and CT Imaging Substudy

T-TEER in a Broad Range of Anatomies: Results From the TRILUMINATE Pivotal Trial

The Future of Transcatheter Tricuspid Intervention: What’s Missing in Technology and Clinical Trials?

Designing Trials to Assess the Effectiveness of New VHD Screening Strategies

Long-term Follow-up in VHD Clinical Trials: Much Needed, BUT Difficult to Do

Requirements for GDMT in UPSTREAM AVR Clinical Trials in (1) Preserved EF or (2) Reduced EF Patients

Phenotypic Diversity in Secondary Mitral Regurgitation: Differential Outcomes Following Transcatheter Edge-to-Edge Repair - Insights From the COAPT and MITRA-FR Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content